PHCG recognized with CEO Cancer Gold Standard accreditation in fight against cancer

NewsGuard 100/100 Score

Publicis Healthcare Communications Group (PHCG), the world's largest healthcare communications group, has received CEO Cancer Gold Standard accreditation, recognizing the organization's commitment to reducing the risk of cancer for employees and their families by promoting healthy lifestyle choices, encouraging early detection through cancer screenings, and ensuring access to quality treatment.

“I hope the commitment demonstrated by PHCG President and CEO, Nick Colucci, will encourage other employers, large and small, to become Gold Standard accredited.”

William C. Weldon, chairman and chief executive officer of Johnson & Johnson, chairs the CEO Roundtable on Cancer, a nonprofit organization of cancer-fighting CEOs who created the CEO Cancer Gold Standard, in collaboration with the National Cancer Institute, many of its designated cancer centers, and leading health non-profit organizations and professionals.

"We are pleased to recognize the efforts of Publicis Healthcare Communications Group in the fight against cancer, starting with improving the health and wellness of their own employees," said Weldon. "I hope the commitment demonstrated by PHCG President and CEO, Nick Colucci, will encourage other employers, large and small, to become Gold Standard accredited."

The CEO Cancer Gold Standard calls for companies to evaluate their health benefits and their corporate culture. To earn Gold Standard accreditation, a company must offer programs and foster a culture that will lower cancer risk. Specifically, they prohibit tobacco use at the workplace and provide support to help employees quit, along with offering programs that encourage physical activity and a healthy diet. Gold Standard employers also cover cancer screenings to increase the likelihood of detecting cancer at its earliest stages when outcomes are more likely to be favorable, and finally, they provide access to quality care, including participation in clinical trials.

Employers are uniquely positioned to lead the fight against cancer and make a real difference in the health and wellbeing of their employees and their family members. The cost of cancer in the workplace is extraordinarily high considering the direct medical costs, lost productivity, disability claims and the tremendous personal toll the disease takes on individuals, families and coworkers. However, a report earlier this year in the journal, Health Affairs, noted that employer medical costs fall by about $3.27 for every dollar spent on wellness programs and that absenteeism costs fall by about $2.73 for every dollar spent.

Today, more than one and a quarter million employees and family members are benefiting from the vision and leadership of employers who have chosen to become Gold Standard accredited. CEO Cancer Gold Standard accreditation is awarded to organizations that demonstrate an exceptional, comprehensive commitment to fighting cancer by focusing on risk reduction, early detection and quality care. While the focus of the Gold Standard is cancer, the benefits of encouraging healthy lifestyle choices extend to other serious and expensive chronic conditions and diseases such as obesity, diabetes, and cardiovascular disease. The Gold Standard sends an important message to employees: "We are investing in your health because we care about you".

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Breakthrough imaging method enhances precision in prostate cancer treatment